These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8382073)

  • 1. Breast cancer chemoprevention.
    Costa A
    Eur J Cancer; 1993; 29A(4):589-92. PubMed ID: 8382073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints.
    Decensi A; Formelli F; Torrisi R; Costa A
    J Cell Biochem Suppl; 1993; 17G():226-33. PubMed ID: 8007703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids and tamoxifen in breast cancer chemoprevention.
    Costa A; Sacchini V; Decensi A
    Int J Clin Lab Res; 1993; 23(2):53-5. PubMed ID: 8518414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of breast cancer with fenretinide.
    Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
    Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
    Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
    Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    De Palo G; Costa A; Formelli F; Del Vecchio M; Marubini E; Veronesi U
    In Vivo; 1993; 7(6B):577-80. PubMed ID: 8193278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR).
    Cassano E; Coopmans de Yoldi G; Ferranti C; Costa A; Mascotti G; De Palo G; Veronesi U
    Eur J Cancer; 1993; 29A(15):2161-3. PubMed ID: 8297658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamoxifen in the treatment of breast cancer].
    Charlier C; Colin C; Merville MP; Gielen J; Lambotte R; Plomteux G; Castronovo V
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):751-6. PubMed ID: 7822705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
    Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
    Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of breast cancer: the Italian experience.
    Decensi A; Bonanni B; Guerrieri-Gonzaga A; Torrisi R; Manetti L; Robertson C; De Palo G; Formelli F; Costa A; Veronesi U
    J Cell Biochem Suppl; 2000; 34():84-96. PubMed ID: 10762020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.
    Decensi A; Torrisi R; Fontana V; Barreca A; Ponzani P; Pensa F; Parodi S; Costa A
    Eur J Cancer; 1998 Jun; 34(7):999-1003. PubMed ID: 9849446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in chemoprevention of breast cancer.
    Serrano D; Perego E; Costa A; Decensi A
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):109-17. PubMed ID: 15012972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.
    Decensi A; Costa A
    Eur J Cancer; 2000 Apr; 36(6):694-709. PubMed ID: 10762741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
    Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
    J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?
    Cazzaniga M; Varricchio C; Montefrancesco C; Feroce I; Guerrieri-Gonzaga A
    J Biomed Biotechnol; 2012; 2012():172897. PubMed ID: 22500077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
    Veronesi U; De Palo G; Marubini E; Costa A; Formelli F; Mariani L; Decensi A; Camerini T; Del Turco MR; Di Mauro MG; Muraca MG; Del Vecchio M; Pinto C; D'Aiuto G; Boni C; Campa T; Magni A; Miceli R; Perloff M; Malone WF; Sporn MB
    J Natl Cancer Inst; 1999 Nov; 91(21):1847-56. PubMed ID: 10547391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Fabian CJ; Kimler BF
    Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.